Celldex Therapeutics, Inc. · NASDAQ:CLDX

T. Rowe Price Associates Inc reported a 5.40% stake in Celldex Therapeutics, Inc. (Schedule 13G)

Event Dec 31, 2024 · Filed Feb 14, 2025

T. Rowe Price Associates Inc reported a 5.40% stake in Celldex Therapeutics, Inc., 3,557,136 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G).

Stake
5.40%
Shares
3,557,136
Intent
Passive
What changed
Crossed above 5%

The filing in full

HolderStakeShares
T. Rowe Price Associates, Inc.5.40%3,557,136

Source

View original at SEC

Related